| |
| |
|
| Insider
Information: |
Lanchbury Jerry S |
| Relationship: |
Chief Scientific Officer |
| City: |
Salt Lake City |
| State: |
UT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
264,324 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,351,706 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
264,324 |
|
|
| Total
Value |
$6,351,706 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Myriad Genetics Inc |
MYGN |
Chief Scientific Officer |
2021-10-09 |
264,324 |
2006-11-07 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
140 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-08-05 |
4 |
OE |
$27.07 |
$764,051 |
D/D |
28,225 |
260,775 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-08-24 |
4 |
OE |
$27.07 |
$812,100 |
D/D |
30,000 |
262,550 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-10-09 |
4 |
D |
$30.88 |
$333,844 |
D/D |
(10,811) |
264,324 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
19,347 |
265,922 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-04-27 |
4 |
AS |
$31.47 |
$1,258,800 |
D/D |
(40,000) |
265,922 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-05-04 |
4 |
AS |
$31.97 |
$618,949 |
D/D |
(19,360) |
265,922 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-07-13 |
4 |
OE |
$26.49 |
$1,146,885 |
D/D |
43,295 |
272,550 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-08-23 |
4 |
OE |
$27.07 |
$1,353,500 |
D/D |
50,000 |
272,550 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-09-26 |
4 |
D |
$33.31 |
$121,015 |
D/D |
(3,633) |
275,135 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-09-25 |
4 |
D |
$33.31 |
$324,673 |
D/D |
(9,747) |
278,768 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-05-04 |
4 |
OE |
$19.47 |
$376,939 |
D/D |
19,360 |
285,282 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-09-23 |
4 |
AS |
$35.06 |
$7,012 |
D/D |
(200) |
288,515 |
0 |
% |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-09-21 |
4 |
A |
$0.00 |
$0 |
D/D |
58,398 |
288,715 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-06-25 |
4 |
OE |
$19.47 |
$973,500 |
D/D |
50,000 |
294,562 |
0 |
- |
|
| MYGN |
Myriad Genetics Inc |
Chief Scientific Officer |
• – – |
2021-04-27 |
4 |
OE |
$19.47 |
$778,800 |
D/D |
40,000 |
305,922 |
0 |
- |
|
140 Records found
|
|
Page 6 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
